University of North Carolina-CH Lineberger Comprehensive Cancer Center is a clinical research site located in Chapel Hill, North Carolina, United States 27599-7295.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
University of North Carolina-CH Lineberger Comprehensive Cancer Center has participated in 1 clinical trials.
Therapeutic areas: Estrogen Receptor Negative (ER-Negative) Breast Cancer, Progesterone Receptor Negative (PR-Negative) Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast Cancer.
Sponsors: Sanofi.
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of North Carolina-CH Lineberger Comprehensive Cancer Center has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of North Carolina-CH Lineberger Comprehensive Cancer Center has 1 clinical trials on record. Their work covers Estrogen Receptor Negative (ER-Negative) Breast Cancer, Progesterone Receptor Negative (PR-Negative) Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast Cancer.
University of North Carolina-CH Lineberger Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.